Marc E Larosee

Title: Marc E. Larosee - A Pioneer in Ocular Therapeutics

Introduction

Marc E. Larosee is an innovative inventor located in Wilmington, MA, known for his contributions to ocular therapeutics. With a focus on applying cutting-edge technology to enhance medical treatments, he has made significant strides in the field of delivering therapeutic agents to ocular tissues.

Latest Patents

Marc holds a notable patent for an "Electrode assembly for delivering a therapeutic agent into ocular tissue." This invention describes a novel contact electrode assembly designed to deliver at least one therapeutic agent directly into the ocular tissue of a subject. The assembly features a flexible dielectric layer with a first and second electrode portion, where the second electrode portion utilizes an interdigitated structure to optimize the delivery of the therapeutic agent. Each component of the assembly is electrically connectable to a signal source, rendering it an effective tool in ocular treatment.

Career Highlights

Currently, Marc E. Larosee is affiliated with the Cleveland Clinic Foundation, a prestigious institution renowned for its commitment to research and innovation in healthcare. His work at the clinic showcases his dedication to improving patient outcomes through technological advancements in medical treatments.

Collaborations

In his professional journey, Marc has collaborated with esteemed colleagues such as Rishi P. Singh and William G. Lionetta. These partnerships within the Cleveland Clinic Foundation underscore the importance of teamwork in driving innovative solutions for complex medical challenges.

Conclusion

Marc E. Larosee's contributions to ocular therapeutics through his innovative patent reflect a commitment to advancing healthcare technology. His work not only exemplifies the spirit of invention but also highlights the impact of collaboration in pushing the boundaries of scientific discovery.